BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.

Autor: Ikonen T; Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland. tarja.ikonen@uta.fi, Matikainen MP, Syrjäkoski K, Mononen N, Koivisto PA, Rökman A, Seppälä EH, Kallioniemi OP, Tammela TL, Schleutker J
Jazyk: angličtina
Zdroj: Journal of medical genetics [J Med Genet] 2003 Aug; Vol. 40 (8), pp. e98.
DOI: 10.1136/jmg.40.8.e98
Databáze: MEDLINE